| Literature DB >> 33260701 |
Harish Chandra1, Chanchal Singh2, Pragati Kumari3, Saurabh Yadav4, Abhay P Mishra5, Aleksey Laishevtcev6,7, Ciprian Brisc8, Mihaela Cristina Brisc8, Mihai Alexandru Munteanu8, Simona Bungau9.
Abstract
Urinary tract infections (UTIs) are considered to be the most common infections worldwide, having an incidence rate of 40-60% in women. Moreover, the prevalence of this disorder in adult women is 30 times more than in men. UTIs are usually found in many hospitals and clinical practice; as disorders, they are complicated and uncomplicated; in uncomplicated cases, there is no structural or functional abnormality in the urogenital tract. However, obstruction, retention of urine flow and use of catheters increase the complexity. There are several bacteria (e.g., E. coli, Klebsiella pneumoniae, Proteus vulgaris, etc.) successfully residing in the tract. The diagnosis must not only be accurate but rapid, so early detection is an important step in the control of UTIs caused by uropathogens. The treatment of UTIs includes appropriate antimicrobial therapy to control the infection and kill the causal microbes inside the body. A long-time usage of antibiotics has resulted in multidrug resistance causing an impediment in treatment. Thus, alternative, combinatorial medication approaches have given some hope. Available treatments considered Homeopathic, Ayurvedic, Unani, and other herbal-based drugs. There are new upcoming roles of nanoparticles in combating UTIs which needs further validation. The role of medicinal plant-based nanotechnology approaches has shown promising results. Therefore, there must be active research in phyto-based therapies of UTIs, such as Ayurvedic Biology.Entities:
Keywords: Ayurvedic; E. coli; UTI; Unani; alternative therapy; homeopathic; nanoparticles; nanotechnology; traditional medicine
Mesh:
Substances:
Year: 2020 PMID: 33260701 PMCID: PMC7731396 DOI: 10.3390/molecules25235593
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Colony characteristics of uropathogens on selective media.
| Culture Media | Colony Characteristic/Color | Probable Bacterium |
|---|---|---|
| CLED | Blue green |
|
| Pink colony with pink halo |
| |
| Golden yellow |
| |
| Orange yellow/Greenish |
| |
| MacConkey Agar | Lactose fermenting pink colony |
|
| Lactose fermenting mucoid pink colony | ||
| CHROM Agar orientation (CHROM agar company, France) | Pink |
|
| Turquoise blue |
| |
| Metallic blue |
| |
| Metallic blue | ||
| Gave golden, opaque small white |
| |
| CPS ID2 medium (bioMe’rieux) | Pink |
|
| Blue Green |
| |
| Brown color |
|
Antibiotics prescribed for the treatment of E. coli UTI.
| Antibiotics | Year | Ref. |
|---|---|---|
| Amoxicillin or bacampicillin | 1990 | [ |
| Nitrofurantoin and trimethoprim-sulfamethoxazole (TMP/SMX) | 1991–1997 | [ |
| Cefixime and Ofloxacin | 1994 | [ |
| Levofloxacin | 2008 | [ |
| Ciprofloxacin | 2015 | [ |
| Cephalexin and Cefuroxime | 2016 | [ |
| Cefotaxime/clavulanic acid | 2020 | [ |
Plants active against uropathogens.
| Plant | Inhibit | Fraction | Ref |
|---|---|---|---|
|
|
| Ethanol, | [ |
|
|
| Ethanol, methanol | [ |
|
|
| Ethanol | [ |
|
|
| Ethanol | [ |
|
|
| Ethanol | [ |
|
|
| Ethanol | [ |
|
|
| Essential oil | [ |
|
| Acetone Methanol | [ | |
|
|
| Methanol | [ |
|
| Ethanol | [ | |
|
| Methanol:dichloromethane (1:1) | [ | |
|
|
| Methanol:dichloromethane (1:1) | [ |
Few metallic nanoparticles and their effectiveness against UTI pathogens.
| Metal NP | Source | Effective Against | Ref. |
|---|---|---|---|
| ZnO-NP |
|
| [ |
| ZnO-NP |
| [ | |
| CuS-NPs |
|
| [ |
| AgNP | Chemical method | [ | |
| AgNP |
|
| [ |
| AgNP | Chemical method |
| [ |
| W-NPs | Chemical method |
| [ |
Figure 1Representation of UTI, prevalence, diagnosis, and treatments.